# Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

- Source: PR Newswire M&A
- Published: 2026-11-01T20:45:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/abbotts-tectonic-clinical-trial-demonstrates-strong-30-day-outcomes-and-high-procedural-success-for-its-investigational-sonicforce-coronary-intravascular-lithotripsy-system-302925602.html
- Canonical: https://groundlevelnews.com/story/abbott-s-tectonic-clinical-trial-demonstrates-strong-30-day-outcomes-a-d16d91/

SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that uses acoustic pressure waves, similar to those used to break up kidney stones, to crack calcium in coronary arteries and restore blood flow The system is designed to bring purposeful innovation to...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._